We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$244M
AUM Growth
-$11.5M
Cap. Flow
-$17.8M
Cap. Flow %
-7.28%
Top 10 Hldgs %
27.75%
Holding
287
New
30
Increased
69
Reduced
110
Closed
41

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$14.6M
2
DIS icon
Walt Disney
DIS
+$10.3M
3
GILD icon
Gilead Sciences
GILD
+$10.2M
4
ABBV icon
AbbVie
ABBV
+$9.79M
5
NLSN
Nielsen Holdings plc
NLSN
+$4.28M

Top Sells

Rank Stock Value
1
CXW icon
CoreCivic
CXW
+$6.9M
2
GEO icon
The GEO Group
GEO
+$6.36M
3
MDU icon
MDU Resources
MDU
+$6.33M
4
SBRA icon
Sabra Healthcare REIT
SBRA
+$5.72M
5
CNA icon
CNA Financial
CNA
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Communication Services 10.2%
3 Technology 10.03%
4 Industrials 8.75%
5 Materials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAFT icon
101
Safety Insurance
SAFT
$1.09B
$872K 0.36%
12,975
-606
-4% -$39.6K
SRC
102
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$866K 0.35%
14,492
-734
-5% -$43.7K
SAVE
103
DELISTED
Spirit Airlines, Inc.
SAVE
$865K 0.35%
20,344
+61
+0.3% +$2.53K
M icon
104
Macy's
M
$6.23B
$852K 0.35%
23,004
-1,165
-5% -$42.2K
LGTY
105
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$839K 0.34%
75,573
-3,414
-4% -$37.1K
IP icon
106
International Paper
IP
$19.9B
$835K 0.34%
18,385
+565
+3% +$24.9K
REGN icon
107
Regeneron Pharmaceuticals
REGN
$70.9B
$821K 0.34%
2,043
-39
-2% -$15.6K
IQNT
108
DELISTED
Inteliquent, Inc.
IQNT
$813K 0.33%
50,399
+110
+0.2% +$1.93K
CVS icon
109
CVS Health
CVS
$137B
$809K 0.33%
9,089
+894
+11% +$84.4K
WFC icon
110
Wells Fargo
WFC
$265B
$790K 0.32%
17,834
-18,320
-51% -$877K
BPL
111
DELISTED
Buckeye Partners, L.P.
BPL
$790K 0.32%
11,028
-2,992
-21% -$213K
LVS icon
112
Las Vegas Sands
LVS
$30.1B
$788K 0.32%
13,691
-638
-4% -$32.9K
F icon
113
Ford
F
$56.7B
$781K 0.32%
64,689
-7,617
-11% -$96.1K
IBM icon
114
IBM
IBM
$200B
$776K 0.32%
5,112
-4,763
-48% -$723K
OGE icon
115
OGE Energy
OGE
$10.1B
$754K 0.31%
23,843
-1,114
-4% -$35.3K
AGR
116
DELISTED
Avangrid, Inc.
AGR
$747K 0.31%
17,882
-838
-4% -$36.6K
BMY icon
117
Bristol-Myers Squibb
BMY
$124B
$744K 0.3%
13,800
+500
+4% +$32.1K
RYN icon
118
Rayonier
RYN
$6.56B
$742K 0.3%
30,818
-1,571
-5% -$38.3K
SBRA icon
119
Sabra Healthcare REIT
SBRA
$5.07B
$741K 0.3%
29,431
-238,922
-89% -$5.72M
PSX icon
120
Phillips 66
PSX
$82.9B
$734K 0.3%
9,114
-2,229
-20% -$173K
TDAY
121
USA Today Co
TDAY
$1.25B
$730K 0.3%
47,101
+1,896
+4% +$32.6K
BBWI icon
122
Bath & Body Works
BBWI
$4.21B
$721K 0.3%
12,595
-784
-6% -$46.2K
AMGN icon
123
Amgen
AMGN
$198B
$713K 0.29%
4,273
+272
+7% +$46K
CCOI icon
124
Cogent Communications
CCOI
$549M
$708K 0.29%
19,224
+683
+4% +$26.4K
UVSP icon
125
Univest Financial
UVSP
$1.24B
$695K 0.28%
29,744
-10,725
-27% -$239K
3 4
5
6 7

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2016 Portfolio in Review

As of Q3 2016, Stanley-Laman Group held 287 positions worth $244M, down 4.5% from $256M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Stanley-Laman Group withdrew a net $17.8M in Q3 2016, closing 41 positions and reducing 110 holdings. Its most notable exit was CoreCivic, an estimated $6.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 11% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Stanley-Laman Group opened a new position in Monsanto Co worth $14.3M.

  • Stanley-Laman Group's largest Q3 2016 buy was Monsanto Co: 139,510 shares worth $14.3M.
  • Stanley-Laman Group added most to Gilead Sciences in Q3 2016, an estimated $10.2M increase.
  • Stanley-Laman Group's biggest Q3 2016 reduction was Sabra Healthcare REIT, cutting an estimated $5.72M.
  • Stanley-Laman Group fully exited CoreCivic in Q3 2016, selling an estimated $6.9M.
  • Stanley-Laman Group's ten largest holdings make up 28% of its $244M portfolio in Q3 2016.
  • Stanley-Laman Group opened 30 new positions and closed 41 in Q3 2016.
  • Stanley-Laman Group's portfolio value fell 4.5% quarter-over-quarter to $244M.

Based on Stanley-Laman Group's 13F filing for Q3 2016, filed 28 Oct 2016.